Riskpilot← Back to searchSign inGet full accessNB Nordic AB
ABBankruptOrg 5569666463Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20140 employees
Revenue 2023
SEK 981K
+8% vs 2022
EBITDA margin
-104.9%
+24% vs 2022
Equity ratio
-76.0%
Financial strength
Net profit 2023
SEK -1M
-19% vs 2022
| Revenue | SEK 981K | +8% |
| EBITDA | SEK -1M | +24% |
| Net profit | SEK -1M | -19% |
| Total assets | SEK 1,2M | -9% |
| Equity | SEK -942K | -1033% |
| Employees | 0 | — |
Legal name
NB Nordic AB
Org number
5569666463
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
27 mars 2014
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget har till föremål för sin verksamhet att bedriva import, export, försäljning, konsultering, service och utbildning av utrustningar och förbrukningsartiklar inom området medicinsk teknik.
Address
Email
peter.suter@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 2 764 | 2 249 | 3 241 | 911 | 981 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −291 | −551 | −286 | −1 355 | −1 029 |
| Depreciation & amort. | −247 | −240 | −222 | −217 | −0 |
| EBIT | −538 | −791 | −508 | −1 572 | −1 029 |
| Net financials | −2 | −1 | — | −2 | −15 |
| Profit before tax | 14 | 25 | −83 | −874 | −1 043 |
| Tax | −9 | −13 | −0 | −0 | −0 |
| Net profit | 5 | 12 | −83 | −874 | −1 043 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 5 529 | 5 026 | 1 858 | 1 358 | 1 239 |
| Equity | 3 546 | 3 558 | 975 | 101 | −942 |
| Long-term debt | 0 | 0 | 0 | 480 | 871 |
| Short-term debt | 741 | 1 043 | 883 | 777 | 1 310 |
| Total debt | 741 | 1 043 | 883 | 1 257 | 2 181 |
EBITDA margin
-104.9%
This company
15.8%
Market median
-764% vs market
20192023
Equity ratio
-76.0%
This company
38.2%
Market median
-299% vs market
20192023
Return on equity
-104300000.0%
This company
18.4%
Market median
-566847926% vs market
20192023
Net profit margin
-106.3%
This company
8.1%
Market median
-1412% vs market
20192023
Asset turnover
0.79×
This company
1.12×
Market median
-29% vs market
20192023
Debt / equity
2.32×
This company
0.62×
Market median
-274% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
BJ Audit | Audit | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2024 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Hundfjället Liftnära AB
NB Nordic AB Board members of NB Nordic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bo Johan Peter Suter | Audit | 0 companies |
| Sven Olof Michael Ohlson | Board of Directors | 0 companies |
| Karen Elke Bittner Gutiérrez | Deputy Board Member | 0 companies |
| Lars-Erik Gunnar Olsson | Deputy Board Member | 0 companies |